Literature DB >> 19193805

Human cytomegalovirus glycoprotein B is required for virus entry and cell-to-cell spread but not for virion attachment, assembly, or egress.

Marisa K Isaacson1, Teresa Compton.   

Abstract

Glycoprotein B (gB) homologs are conserved throughout the family Herpesviridae and appear to serve essential, universal functions, as well as specific functions unique to a particular herpesvirus. Genetic analysis is a powerful tool to analyze protein function, and while it has been possible to generate virus mutants, complementation of essential virus knockouts has been problematic. Human cytomegalovirus (HCMV) gB (UL55) plays an essential role in the replication cycle of the virus. To define the function(s) of gB in HCMV infection, the BAC system was used to generate a recombinant virus in which the UL55 gene was replaced with galK (pAD/CreDeltaUL55). UL55 deletions in the viral genome have been made before, demonstrating that UL55 is an essential gene. However, without being able to successfully complement the genetic defect, a phenotypic analysis of the mutant virus was impossible. We generated fibroblasts expressing HCMV gB that complement pAD/CreDeltaUL55 and produce infectious virions lacking the UL55 gene but containing wild-type gB on the virion surface (DeltaUL55-gB HCMV). This is the first successful complementation of an HCMV mutant with a glycoprotein deleted. To characterize DeltaUL55 infection in the absence of gB, noncomplementing cells were infected with DeltaUL55-gB virus. All stages of gene expression were detected, and significant amounts of DNase-resistant viral DNA genomes, representing whole intact virions, were released into the infected cell supernatant. Gradient purification of these virions revealed they lacked gB but contained other viral structural proteins. The gB-null virions were able to attach to the cell surface similarly to wild-type gB-containing virions but were defective in virus entry and cell-to-cell spread. Glycoprotein B-null virions do, however, contain infectious DNA, as IE gene expression can be detected in fibroblasts following treatment of attached gB-null virions with a membrane fusion agent, polyethylene glycol. Taken together, our results indicate that gB is required for virus entry and cell-to-cell spread of the virus. However, HCMV gB is not absolutely required for virus attachment or assembly and egress from infected cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19193805      PMCID: PMC2663263          DOI: 10.1128/JVI.01251-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  63 in total

1.  Functional map of human cytomegalovirus AD169 defined by global mutational analysis.

Authors:  Dong Yu; Maria C Silva; Thomas Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-30       Impact factor: 11.205

2.  Characterization of cell-cell fusion mediated by herpes simplex virus 2 glycoproteins gB, gD, gH and gL in transfected cells.

Authors:  Martin I Muggeridge
Journal:  J Gen Virol       Date:  2000-08       Impact factor: 3.891

3.  Glycoprotein 110, the Epstein-Barr virus homolog of herpes simplex virus glycoprotein B, is essential for Epstein-Barr virus replication in vivo.

Authors:  R E Herrold; A Marchini; S Fruehling; R Longnecker
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

4.  Receptor-binding properties of a soluble form of human cytomegalovirus glycoprotein B.

Authors:  K A Boyle; T Compton
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

5.  Human cytomegalovirus pp71 stimulates cell cycle progression by inducing the proteasome-dependent degradation of the retinoblastoma family of tumor suppressors.

Authors:  Robert F Kalejta; Jill T Bechtel; Thomas Shenk
Journal:  Mol Cell Biol       Date:  2003-03       Impact factor: 4.272

6.  The varicella zoster virus glycoprotein B (gB) plays a role in virus binding to cell surface heparan sulfate proteoglycans.

Authors:  A Jacquet; M Haumont; D Chellun; M Massaer; F Tufaro; A Bollen; P Jacobs
Journal:  Virus Res       Date:  1998-02       Impact factor: 3.303

7.  Pseudorabies virus glycoproteins gII and gp50 are essential for virus penetration.

Authors:  I Rauh; T C Mettenleiter
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

8.  Neutralizing mechanisms of two human monoclonal antibodies against human cytomegalovirus glycoprotein 130/55.

Authors:  Y Ohizumi; H Suzuki; Y Matsumoto; Y Masuho; Y Numazaki
Journal:  J Gen Virol       Date:  1992-10       Impact factor: 3.891

9.  Human cytomegalovirus induces cellular tyrosine kinase signaling and promotes glioma cell invasiveness.

Authors:  Charles S Cobbs; Liliana Soroceanu; Scott Denham; Wenyue Zhang; William J Britt; Russ Pieper; Matthias H Kraus
Journal:  J Neurooncol       Date:  2007-06-23       Impact factor: 4.130

10.  A human cytomegalovirus glycoprotein complex designated gC-II is a major heparin-binding component of the envelope.

Authors:  B Kari; R Gehrz
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

View more
  83 in total

1.  Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds.

Authors:  Chen-Jei Tai; Chia-Lin Li; Cheng-Jeng Tai; Chien-Kai Wang; Liang-Tzung Lin
Journal:  J Vis Exp       Date:  2015-10-29       Impact factor: 1.355

2.  Human cytomegalovirus glycoprotein B variants affect viral entry, cell fusion, and genome stability.

Authors:  Jiajia Tang; Giada Frascaroli; Robert J Lebbink; Eleonore Ostermann; Wolfram Brune
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-19       Impact factor: 11.205

3.  The Human Cytomegalovirus Trimer and Pentamer Promote Sequential Steps in Entry into Epithelial and Endothelial Cells at Cell Surfaces and Endosomes.

Authors:  Jing Liu; Ted S Jardetzky; Andrea L Chin; David C Johnson; Adam L Vanarsdall
Journal:  J Virol       Date:  2018-10-12       Impact factor: 5.103

Review 4.  Human cytomegalovirus entry into cells.

Authors:  Adam L Vanarsdall; David C Johnson
Journal:  Curr Opin Virol       Date:  2012-01-30       Impact factor: 7.090

5.  Human Cytomegalovirus Glycoprotein-Initiated Signaling Mediates the Aberrant Activation of Akt.

Authors:  Jamil Mahmud; Michael J Miller; Aaron M Altman; Gary C Chan
Journal:  J Virol       Date:  2020-07-30       Impact factor: 5.103

6.  Immune Correlates of Protection Against Human Cytomegalovirus Acquisition, Replication, and Disease.

Authors:  Cody S Nelson; Ilona Baraniak; Daniele Lilleri; Matthew B Reeves; Paul D Griffiths; Sallie R Permar
Journal:  J Infect Dis       Date:  2020-03-05       Impact factor: 5.226

7.  Human Cytomegalovirus nuclear egress and secondary envelopment are negatively affected in the absence of cellular p53.

Authors:  Man I Kuan; John M O'Dowd; Kamila Chughtai; Ian Hayman; Celeste J Brown; Elizabeth A Fortunato
Journal:  Virology       Date:  2016-08-05       Impact factor: 3.616

8.  Mechanism for neutralizing activity by the anti-CMV gH/gL monoclonal antibody MSL-109.

Authors:  Ashley E Fouts; Laëtitia Comps-Agrar; Katharina F Stengel; Diego Ellerman; Allyn J Schoeffler; Søren Warming; Dan L Eaton; Becket Feierbach
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-19       Impact factor: 11.205

9.  Dynamics of Human Cytomegalovirus Infection in CD34+ Hematopoietic Cells and Derived Langerhans-Type Dendritic Cells.

Authors:  Roxanne Coronel; Sachiko Takayama; Timothy Juwono; Laura Hertel
Journal:  J Virol       Date:  2015-03-11       Impact factor: 5.103

10.  A vaccine based on the rhesus cytomegalovirus UL128 complex induces broadly neutralizing antibodies in rhesus macaques.

Authors:  Felix Wussow; Yujuan Yue; Joy Martinez; Jesse D Deere; Jeff Longmate; Andreas Herrmann; Peter A Barry; Don J Diamond
Journal:  J Virol       Date:  2012-11-14       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.